4//SEC Filing
Peluso Stephane 4
Accession 0001140361-22-001474
CIK 0001113148other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:00 PM ET
Size
5.2 KB
Accession
0001140361-22-001474
Insider Transaction Report
Form 4
Peluso Stephane
Chief Scientific Officer
Transactions
- Award
Stock Option(right to buy)
2022-01-11+87,027→ 87,027 totalExercise: $1.53Exp: 2032-01-11→ Common Stock (87,027 underlying)
Footnotes (1)
- [F1]The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001875939
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:00 PM ET
- Size
- 5.2 KB